JACQUELINE CHANDLER: Open Payments
NPI 1689111478 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$476 in 23 payments from 12 companies in 2025. Trend: 2023 $206 · 2024 $550 · 2025 $476
Food & beverage: $476
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $110 |
| Lilly USA, LLC | 3 | $67 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Amgen Inc. | 2 | $37 |
| Exact Sciences Corporation | 2 | $36 |
| Neurocrine BioSciences, Inc. | 1 | $33 |
| Edwards Lifesciences Corporation | 1 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| Astellas Pharma US Inc | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
Products named: MOUNJARO, Ozempic, EVENITY, The Cologuard Plus Collection Kit, Wegovy, BREZTRI, INGREZZA, SAPIEN 3 Ultra RESILIA.
Industry payments across IN — which companies pay providers there.
